VTE-BLEED Score

• This tool is not intended to definitively exclude patients from anticoagulation therapy. 
• Clinicians must weigh the risks of thrombosis and bleeding and engage patients in discussions that tailor management to their clinical context and preferences.

Score ≥2: Indicates an elevated bleeding risk. Consider: 

• Closer monitoring.
• Careful medication selection (e.g., DOAC versus VKA).
• Dose adjustment (e.g., prophylactic versus therapeutic dosing after a designated period).
• Shorter anticoagulation duration (e.g., 3 months versus 6 months).
• Managing modifiable risk factors.
• Evaluating the use of non-anticoagulant strategies.

Score <2: Indicates a low bleeding risk. Pursue anticoagulation therapy as indicated with routine monitoring.